Loading…
Astal Laboratories (BSE 512600)₹59.93−0.12%Pharmaceuticals
At the end of the Jun 2026 quarter, Astal Laboratories' shareholders were: promoters 4.51%, public 95.49%. Promoter holding is down 0.17 percentage points from 4.68% a quarter earlier. It had 3,273 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 55.70% | 39.77% | 19.91% | 19.91% | 19.91% | 19.91% | 19.91% | 19.91% | 18.17% | 18.17% | 4.68% | 4.51% |
| Public | 44.30% | 60.23% | 80.09% | 80.09% | 80.09% | 80.09% | 80.09% | 80.09% | 81.83% | 81.83% | 95.32% | 95.49% |
| Number of shareholders | 1,168 | 1,184 | 1,240 | 1,241 | 1,628 | 1,924 | 2,301 | 2,720 | 2,898 | 2,925 | 3,064 | 3,273 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Sesha Sai Nikhil Chintalapati | Public | 11.42% | −0.43 |
| Suryanarayana Raju Rudraraju . | Public | 6.74% | −0.25 |
| Kommera Harish | Public | 6.44% | −0.24 |
| Amit Mishra | Public | 4.61% | −0.17 |
| Aceso Research Labs Llp | Promoter | 4.52% | −0.17 |
| Abraham George | Public | 4.44% | −0.10 |
| Liju Mathew | Public | 3.80% | −0.14 |
| Pavani Vupparapalli | Public | 3.74% | +0.44 |
| Venkataramana Reddy Mallela | Public | 2.87% | −0.11 |
| Pradeepkumar M G | Public | 2.64% | −0.10 |
| Doradla Radha Krishna | Public | 2.59% | −0.10 |
| K S Srinivas Rao | Public | 1.89% | −0.07 |
| Kunapareddy Bala Gopala Krishna Rao . | Public | 1.27% | +0.18 |
| Nitin Gupta | Public | 1.15% | −0.04 |
Promoters held 4.51% of Astal Laboratories at the end of the Jun 2026 quarter, down 15.40 percentage points from 19.91% a year earlier.
Astal Laboratories had 3,273 shareholders at the end of the Jun 2026 quarter, against 2,720 a year earlier.
Sesha Sai Nikhil Chintalapati (Public) held 11.42% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.